SEC Filings HubLive
Live feed
Filing

Form 4

Form 4
0001104659-26-107916·AgomAb Therapeutics NV

Filing metadata

Accession number
0001104659-26-107916
Form type
Form 4
Filer
AgomAb Therapeutics NV
CIK
CIK 2020932
Filed
Sep 15, 2026
Reporting period
Sep 11, 2026
Description
Insider transaction

Documents

Filed by